NAMA
Nikko Asset Management Americas’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $117M | Sell |
2,414,271
-125,618
| -5% | -$6.11M | 1.17% | 23 |
|
2025
Q1 | $86.3M | Sell |
2,539,889
-205,787
| -7% | -$6.99M | 1.11% | 24 |
|
2024
Q4 | $108M | Sell |
2,745,676
-221,543
| -7% | -$8.72M | 1.17% | 25 |
|
2024
Q3 | $139M | Sell |
2,967,219
-184,295
| -6% | -$8.66M | 1.58% | 19 |
|
2024
Q2 | $170M | Sell |
3,151,514
-117,271
| -4% | -$6.33M | 1.96% | 16 |
|
2024
Q1 | $223M | Sell |
3,268,785
-100,977
| -3% | -$6.88M | 2.21% | 13 |
|
2023
Q4 | $211M | Sell |
3,369,762
-95,708
| -3% | -$5.99M | 2.03% | 13 |
|
2023
Q3 | $157M | Sell |
3,465,470
-67,887
| -2% | -$3.08M | 1.88% | 14 |
|
2023
Q2 | $198M | Sell |
3,533,357
-438,782
| -11% | -$24.6M | 2.09% | 15 |
|
2023
Q1 | $179M | Sell |
3,972,139
-34,337
| -0.9% | -$1.55M | 2.06% | 16 |
|
2022
Q4 | $163M | Sell |
4,006,476
-256,260
| -6% | -$10.4M | 2.35% | 14 |
|
2022
Q3 | $277M | Sell |
4,262,736
-321,362
| -7% | -$20.9M | 3.54% | 9 |
|
2022
Q2 | $276M | Sell |
4,584,098
-35,649
| -0.8% | -$2.15M | 3.41% | 9 |
|
2022
Q1 | $291M | Buy |
4,619,747
+300,276
| +7% | +$18.9M | 2.14% | 15 |
|
2021
Q4 | $331M | Buy |
4,319,471
+1,029,955
| +31% | +$78.8M | 1.74% | 17 |
|
2021
Q3 | $368M | Sell |
3,289,516
-93,940
| -3% | -$10.5M | 1.58% | 21 |
|
2021
Q2 | $548M | Sell |
3,383,456
-276,409
| -8% | -$44.8M | 2.15% | 13 |
|
2021
Q1 | $446M | Sell |
3,659,865
-176,958
| -5% | -$21.6M | 2.18% | 11 |
|
2020
Q4 | $587M | Buy |
3,836,823
+139,156
| +4% | +$21.3M | 3.34% | 4 |
|
2020
Q3 | $309M | Sell |
3,697,667
-14,303
| -0.4% | -$1.19M | 2.74% | 7 |
|
2020
Q2 | $269M | Sell |
3,711,970
-54,571
| -1% | -$3.96M | 3.53% | 5 |
|
2020
Q1 | $160M | Buy |
3,766,541
+716,988
| +24% | +$30.4M | 2.97% | 6 |
|
2019
Q4 | $186M | Buy |
3,049,553
+272,139
| +10% | +$16.6M | 2.92% | 6 |
|
2019
Q3 | $114M | Buy |
2,777,414
+906,006
| +48% | +$37.1M | 2.02% | 13 |
|
2019
Q2 | $88.1M | Buy |
1,871,408
+1,430,364
| +324% | +$67.4M | 1.73% | 16 |
|
2019
Q1 | $15.8M | Buy |
441,044
+440,120
| +47,632% | +$15.7M | 0.42% | 50 |
|
2018
Q4 | $26K | Sell |
924
-200
| -18% | -$5.63K | ﹤0.01% | 137 |
|
2018
Q3 | $50K | Buy |
+1,124
| New | +$50K | ﹤0.01% | 132 |
|